News
Leading Experts to Speak at Focused Ultrasound Symposium
June 25, 2010 6:33 am | by Bio-Medicine.Org | CommentsFocused Ultrasound Surgery Foundation Announces Speakers, Moderators and Panelists for 2nd International Symposium on MR-Guided Focused Ultrasound CHARLOTTESVILLE, Va. , June 25 /PRNewswire-USNewswire/ -- Leading research and clinical experts from around the world are scheduled to speak...
CGI Pharma to be sold to Calif. firm for $120M
June 25, 2010 5:35 am | by Mass High Tech: The Journal of New England Technology | CommentsCGI Pharmaceuticals Inc., a small-molecule-focused biotech in Branford, Conn., has signed a deal to be acquired by Gilead Sciences Inc. for up to $120 million. The buyout is planned to close in the third quarter of 2010.
Archimedes Pharma Receives CHMP Positive Opinion for PecFent(R) for the Treatment of Breakthrough Cancer Pain
June 25, 2010 5:34 am | by Bio-Medicine.Org | CommentsREADING, England , June 25, 2010 /- Archimedes Pharma ("Archimedes"), a leading specialty pharma company, today announced that its lead product, PecFent*, has received a Positive Opinion from the Committee for Human Medicinal Products (CHMP), of the European Medicines Agency (EMA). The...
Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVaxâ„¢ Administration
June 25, 2010 5:34 am | by Bio-Medicine.Org | CommentsPRINCETON, N.J. , June 25 /- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today the publication of an article in the June 2010 edition of Vaccine , which describes protection from mucosal and systemic ricin...
Phase 1 trial triggers $1M payment for ImmunoGen
June 25, 2010 5:34 am | by Mass High Tech: The Journal of New England Technology | CommentsBiotech firm ImmunoGen Inc. is in line for a $1 million milestone payment from sanofi-aventis, now that sanofi has launched a Phase 1 clinical trial of ImmunoGen's SAR650984 investigational antibody.
Tenet Healthcare named AIG director to its board
June 25, 2010 3:45 am | by The Associated Press | CommentsHospital operator Tenet Healthcare Corp. said Friday it named Ronald Rittenmeyer, former CEO of Electronic Data Systems Corp., to a vacancy on its board.Rittenmeyer, 63, replaces Don Williams, who retired from Tenet in May.Rittenmayer is the former chairman, president and CEO of EDS and has...
EpiWorks demonstrates 6-Inch CS-based PV solar production
June 25, 2010 1:34 am | by I-Micronews | CommentsEpiWorks, a developer and producer of compound semi epitaxial wafers based in Champaign-Urbana, Illinois, reportedly demonstrated its ability to produce 6-inch compound semi-based PV wafers.
Nightingale-EOS Ltd unveils the n-Gauge? metrology tool
June 25, 2010 12:33 am | by I-Micronews | CommentsNightingale-EOS Limited (Wrexham, UK) has launched its first product, the n-Gauge? metrology tool for characterising the thickness and material properties of thin film coatings on a wide range of devices
Reportlinker Adds Global Hernia Repair Devices Industry
June 24, 2010 10:36 pm | by Bio-Medicine.Org | CommentsNEW YORK , June 24 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Hernia Repair Devices Industry http://www.reportlinker.com/p0209282/Global-Hernia-Repair-Devices-Indust... This report analyzes the Global marke...
IDRI and PATH Enter into Research Collaboration Agreement to Evaluate Novel Adjuvants to Enhance Pandemic Influenza Vaccines
June 24, 2010 10:36 pm | by Bio-Medicine.Org | CommentsSEATTLE , June 25 /PRNewswire-USNewswire/ -- Two global health non-profit organizations headquartered in Seattle, Washington , the Infectious Disease Research Institute (IDRI) and PATH, have entered into a Research Collaboration Agreement to evaluate novel adjuvants for their ability to...
New ISHLT cardiac allograft vasculopathy standardized nomenclature
June 24, 2010 10:34 pm | by EurekAlert | Comments(Elsevier Health Sciences) Cardiac allograft vasculopathy (CAV), the major limitation to long term survival after heart transplantation, can lead to dysfunction of the heart muscle or sudden death. Appropriate treatment for this condition has been hampered because of the lack of a...
Reportlinker Adds US Enzyme-Linked Immunosorbent Assay (ELISA) Industry
June 24, 2010 10:34 pm | by Bio-Medicine.Org | CommentsNEW YORK , June 24 /- Reportlinker.com announces that a new market research report is available in its catalogue: US Enzyme-Linked Immunosorbent Assay (ELISA) Industry http://www.reportlinker.com/p0209258/US-Enzyme-Linked-Immunosorbent-Assa... This re...
New diagnostic test for bladder cancer
June 24, 2010 10:34 pm | by EurekAlert | Comments(American Journal of Pathology) Researchers from the Danish Cancer Society and the Herlev University Hospital of Copenhagen have developed a novel assay to test for multiple tumor markers in bladder cancer. The related report by Serizawa et al, "Custom-designed MLPA using multiple...
Moody's gives Universal Health speculative rating
June 24, 2010 1:45 pm | by The Associated Press | CommentsMoody's Investors Service assigned a "Ba2," or "speculative" rating on Thursday to hospital operator Universal Health Services Inc.'s corporate family and probability of default ratings."The assignment of the 'Ba2' corporate family rating reflects the significant increase in leverage incurred...
UN Global Compact, Accenture Release Findings of Largest CEO Research Study on Corporate Sustainability
June 24, 2010 12:37 pm | by Material Handling Industry of America | CommentsIn spite of the recent economic downturn, an overwhelming majority of corporate CEOs – 93 percent – say that sustainability will be critical to the future success of their companies. Furthermore, CEOs believe that, within a decade, a tipping
